XML 40 R27.htm IDEA: XBRL DOCUMENT v3.26.1

REVENUE RECOGNITION (Tables)

3 Months Ended

Mar. 31, 2026

Revenue from Contract with Customer [Abstract]

SCHEDULE OF DISAGGREGATED BY PRODUCT

Revenue disaggregated by product for the three months ended March 31, 2026 and 2025 is as follows:

 SCHEDULE OF DISAGGREGATED BY PRODUCT

Product		2026				2025
		Three Months Ended
		March 31,
Product		2026				2025
ARBLI™ (SCN-102, Losartan Potassium Oral Suspension)		$	56,325			$	-
Pharmaceutical product resale			-				10,258
Total revenues		$	56,325			$	10,258

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration